Elevations of cardiac troponin (cTn), particularly cardiac troponin T (cTnT), are common in non-cardiac diseases and may complicate clinical decision making and potentially lead to unnecessary invasive procedures. The currently used commercial high-sensitivity cTnT (hs-cTnT) assay detects all circulating cTnT mol...
S. Knudsen, R. Hasselbalch, N. Strandkjær et al.· European Heart Journal· 0 citations
Cardiac troponins (cTn) are central to the diagnosis of acute coronary syndrome. Fulfilment of the criteria for myocardial injury (cTn>99th percentile) is common in non-cardiac diseases and cTn-release mechanisms remain incompletely understood. Cardiac troponin T (cTnT) release from skeletal muscle has been demon...
S. Knudsen, R. Hasselbalch, N. Strandkjær et al.· European Heart Journal· 0 citations
In patients with non-cardiac diseases, hs-cTnT elevations were significantly more prevalent than hs-cTnI elevations, suggesting distinct underlying mechanisms of myocardial injury and supporting a disease-specific of troponin elevations beyond ACS.
S. Knudsen, R. Hasselbalch, N. Strandkjær et al.· European Heart Journal· 0 citations
BACKGROUND
Long forms of cardiac troponin T (cTnT) are promising markers that may differentiate myocardial infarction from other causes of acute and chronic myocardial injury. However, to understand the clinical utility of long cTnT, knowledge of the half-life (T½) is key. By using auto-transfusion in humans we determi...
R. Hasselbalch, S. Salonen, J. Kristensen et al.· The Journal of Applied Labor...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.